rs7156352

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001172.4(ARG2):​c.184+7953T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.774 in 152,194 control chromosomes in the GnomAD database, including 46,494 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 46494 hom., cov: 33)

Consequence

ARG2
NM_001172.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0450

Publications

2 publications found
Variant links:
Genes affected
ARG2 (HGNC:664): (arginase 2) Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.924 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001172.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
NM_001172.4
MANE Select
c.184+7953T>C
intron
N/ANP_001163.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
ENST00000261783.4
TSL:1 MANE Select
c.184+7953T>C
intron
N/AENSP00000261783.3
ENSG00000286861
ENST00000662787.1
n.1505A>G
non_coding_transcript_exon
Exon 2 of 2
ARG2
ENST00000556491.1
TSL:5
n.182+7953T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.774
AC:
117665
AN:
152076
Hom.:
46424
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.932
Gnomad AMI
AF:
0.508
Gnomad AMR
AF:
0.821
Gnomad ASJ
AF:
0.651
Gnomad EAS
AF:
0.700
Gnomad SAS
AF:
0.738
Gnomad FIN
AF:
0.687
Gnomad MID
AF:
0.826
Gnomad NFE
AF:
0.697
Gnomad OTH
AF:
0.791
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.774
AC:
117795
AN:
152194
Hom.:
46494
Cov.:
33
AF XY:
0.773
AC XY:
57512
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.932
AC:
38751
AN:
41566
American (AMR)
AF:
0.821
AC:
12553
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.651
AC:
2258
AN:
3468
East Asian (EAS)
AF:
0.701
AC:
3629
AN:
5180
South Asian (SAS)
AF:
0.738
AC:
3562
AN:
4826
European-Finnish (FIN)
AF:
0.687
AC:
7249
AN:
10556
Middle Eastern (MID)
AF:
0.830
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
0.697
AC:
47413
AN:
67998
Other (OTH)
AF:
0.793
AC:
1674
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1318
2637
3955
5274
6592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.742
Hom.:
5260
Bravo
AF:
0.791
Asia WGS
AF:
0.756
AC:
2631
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.77
DANN
Benign
0.75
PhyloP100
-0.045
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7156352; hg19: chr14-68095636; API